These findings support our observations that CREB3L2 knockdown in myeloma cells increases E-cadherin, decreases vimentin, upregulates Bax, and downregulates Bcl-2, indicating suppression of EMT-like and anti-apoptotic programs. This evidence concerns the gene CREB3L2 and plasma cell myeloma.